| Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377) |
|---|
| 03/30/2005 | CN1194980C Phosphonocephem derivatives, process for preparation of same, and use thereof |
| 03/30/2005 | CN1194979C Medical radioactive rhenium-aminophosphonic acid compound and preparing process thereof |
| 03/30/2005 | CN1194978C Phosphinous and phosphonic acid derivs. used as medicaments |
| 03/29/2005 | US6872863 Methylene bridged metallocenes as olefin-polymerization catalyst components |
| 03/29/2005 | US6872838 Derivatives of water insoluble drugs which exhibit good activity and water solubility |
| 03/29/2005 | US6872828 Analyzing using peroxy compound |
| 03/29/2005 | US6872712 Cyclic glycerophosphates and analogs thereof |
| 03/29/2005 | US6872711 β-substituted β-aminoethyl phosphonate derivatives |
| 03/29/2005 | US6872701 Glycopeptide phosphonate derivatives |
| 03/29/2005 | US6872420 Methods for preparing ruthenium and osmium compounds and films |
| 03/29/2005 | CA2102750C Substituted triazolinones |
| 03/24/2005 | WO2005026131A1 Transition state structure and inhibitors of thymidine phosphorylases |
| 03/24/2005 | WO2005026128A1 Ophthalmic compositions for treating ocular hypertension |
| 03/24/2005 | WO2005012220A3 Cycloalkylidene compounds as modulators of estrogen receptor |
| 03/24/2005 | WO2005009348A3 Substituted purine derivatives |
| 03/24/2005 | WO2004111193A3 Prodrugs of mitotic kinesin inhibitors |
| 03/24/2005 | WO2004104015A3 Mannose-6-phosphonate compounds for the treatment of inflammatory diseases |
| 03/24/2005 | WO2004009878A3 Electrochemical processing cell |
| 03/24/2005 | US20050065353 Mitosis agents; antitumor agents; anticancer agents |
| 03/24/2005 | US20050065217 Trimethoxyphenyl indole ligandl cytiotoxic: anticancer agents |
| 03/24/2005 | US20050065174 Novel chain-breaking antioxidants |
| 03/24/2005 | US20050065171 Therapy, prevention leukemia; antitumor agents |
| 03/24/2005 | US20050065119 Alkoxyamines derived from beta-phosphorylated nitroxides, and use thereof for preparing polymerized or non-polymerized mono-or polyalkoxyamines |
| 03/24/2005 | US20050065097 Liver disorders; antiarrhythmia agents; anticancer agents; astaxanthin |
| 03/24/2005 | US20050065096 Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease |
| 03/24/2005 | US20050065033 Method to inhibit ethylene responses in plants |
| 03/24/2005 | US20050064532 Compounds for determining the activity of phospholipase a2? |
| 03/23/2005 | EP1517387A1 Supporting electrolyte for cell and method for production thereof, and cell |
| 03/23/2005 | EP1516880A1 Chiral phosphines for use in asymmetric synthesis |
| 03/23/2005 | EP1516015A1 Low acidity phosphate esters |
| 03/23/2005 | EP1515978A1 Sulfur-containing phospholipid derivatives |
| 03/23/2005 | EP1515950A1 Cationic alkoxyamines and their use in producing nano particles from natural or synthetic clays |
| 03/23/2005 | EP1515937A1 Diaryliodonium salt catalysts made from iodotoluene and a method for preparing them |
| 03/23/2005 | EP1515934A1 Method for producing c13-alcohol mixtures |
| 03/23/2005 | CN1599743A Ligands for use in catalytic processes |
| 03/23/2005 | CN1597686A 含磷化合物 Phosphorus-containing compounds |
| 03/22/2005 | US6870657 Electrode is coated with a nanostructured metal oxide film, modifying by a redox chromophore chemisorption, and electrolyte; used in optical modulators, static displays and dimmable rear-view mirrors |
| 03/22/2005 | US6870039 Synthesizing phosphorothioate oligonucleotides and their intermediates; used in genomic research as probes, primers and alsoin diagnositics |
| 03/22/2005 | US6870021 Mixtures of condensation polymers comprising organonitrogen or organosulfur polymers and curing agents, having preferential binding, used for analysis, separation and resolution of racemic mixtures |
| 03/22/2005 | US6869974 Pharmaceutical compounds |
| 03/22/2005 | US6869952 Such as 4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methyl-pyrrolo(2,1-f)(1,2,4)triazin-6-ol; for treament of cancer |
| 03/22/2005 | US6869904 Bridged bi-aromatic ligands, catalysts, processes for polymerizing and polymers therefrom |
| 03/22/2005 | US6869593 Diagnosis of anticholesterol agents; cardiovascular disorders; in situ detection of apatite |
| 03/22/2005 | CA2434499C Improved method for refining vegetable oil |
| 03/22/2005 | CA2225250C Bicyclic amino derivatives and pgd2 antagonist containing the same |
| 03/22/2005 | CA2178219C Substituted morpholine derivatives and their use as therapeutic agents |
| 03/17/2005 | WO2005023844A1 Compound modified with glycerol derivative |
| 03/17/2005 | WO2005023823A1 Preparation of aryl phosphines |
| 03/17/2005 | WO2005023822A1 Perfluoropolyether amide-linked phosphonates, phosphates, and derivatives thereof |
| 03/17/2005 | WO2005023267A1 Cyclohexyl prostaglandin analogs as ep4-receptor agonists |
| 03/17/2005 | WO2005023251A1 N3 alkylated benzimidazole derivatives as mek inhibitors |
| 03/17/2005 | WO2004106288A3 Ionic liquids containing guanidinium cations |
| 03/17/2005 | WO2004104014A3 Chiral ligands and their transition metal complexes |
| 03/17/2005 | WO2004101579A3 Substituted phosphonate fluorescent sensors and use thereof |
| 03/17/2005 | WO2004089920A3 Amine-substituted diphenyldiphosphines and the use thereof in metal complexes for asymmetric syntheses |
| 03/17/2005 | WO2004087061A3 Tubulin binding agents and corresponding prodrug constructs |
| 03/17/2005 | WO2004059036A3 Hydrophobic-hydrophilic compounds for treating metallic surfaces |
| 03/17/2005 | WO2003037887A8 Therapeutic isoquinoline compounds |
| 03/17/2005 | US20050059840 Process for recovering a crystalline product from solution |
| 03/17/2005 | US20050059728 Dithiolane derivatives for immobilising biomolecules on noble metals and semiconductors |
| 03/17/2005 | US20050059659 Carotenoid analogs or derivatives for controlling C-reactive protein levels |
| 03/17/2005 | US20050059637 Nucleobase phosphonate analogs for antiviral treatment |
| 03/17/2005 | US20050059635 Astaxanthin, beta-carotene, zeanthin, canthaxanthin |
| 03/17/2005 | US20050058635 Anticancer agents; therapy for infections; administering glutaminyl cyclase inhibitor; Alzheimer's disease; Down syndrome; controlling fertility; schizophrenia; skin disorders |
| 03/17/2005 | US20050058601 Polypodal chelants for metallopharmaceuticals |
| 03/17/2005 | US20050056293 Reduced ignition propensity smoking article |
| 03/17/2005 | DE10338731B4 Verfahren zur Herstellung einer (RO)(R'O)(R''O)M=O-Verbindung, dünnschichtbildendes Material, Dünnschicht und Halbleiterelement A process for producing a (RO) (R'O) (R''O) M = O compound thin film forming material, and thin-film semiconductor element |
| 03/17/2005 | DE10338131A1 Verfahren zur Herstellung von 9,10-Dihydro-9-oxa-10-organyloxy-phosphaphenanthren-10-oxid oder -thion und an den Phenylgruppen substitutierten Derivaten desselben The same process for the preparation of 9,10-dihydro-9-oxa-10-phosphaphenanthrene-10-organyloxy-oxide or -thione and derivatives substituted on the phenyl |
| 03/17/2005 | DE10338116A1 Verfahren zur Herstellung von 9,10-Dihydro-9-oxa-10-organyl-phosphaphenanthren-10-oxid und an den Phenylgruppen substituierten Derivaten desselben Process for the preparation of 9,10-dihydro-9-oxa-10-phosphaphenanthrene-10-organyl-oxide and on the phenyl groups substituted derivatives thereof |
| 03/17/2005 | DE10337761A1 Phosphororganische 4-Iminohydantoinderivate Organophosphorus 4-Iminohydantoinderivate |
| 03/17/2005 | CA2537252A1 Cyclohexyl prostaglandin analogs as ep4-receptor agonists |
| 03/17/2005 | CA2537098A1 N3 alkylated benzimidazole derivatives as mek inhibitors |
| 03/16/2005 | EP1514872A1 Phosphorylated glyceryl ether aluminium salts |
| 03/16/2005 | EP1513853A2 Cardiolipin compositions, methods of preparation and use |
| 03/16/2005 | EP1513852A1 Phosphatidyl oligo glycerins and structural analogs |
| 03/16/2005 | EP1513849A1 Shaped bodies containing metal-organic frameworks |
| 03/16/2005 | EP1341799B1 P-chirale bisphospholane ligands, their transition metal complexes |
| 03/16/2005 | EP1225978B1 Hydroformylation of unsaturated compounds using polymeric phosphite ligands |
| 03/16/2005 | EP1203091B1 Chemiluminescent substrates of hydrolytic enzymes such as phosphatases |
| 03/16/2005 | EP1115758B1 Polymerization of olefins |
| 03/16/2005 | EP0758324B1 Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
| 03/16/2005 | EP0746321B1 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
| 03/16/2005 | CN1596262A Phosphorus-borates with low melting points |
| 03/16/2005 | CN1596261A Bidentate ligands for the carbonylation of unsaturated compounds |
| 03/16/2005 | CN1596152A Process for the preparation of a nickel/phosphorous ligand catalyst for olefin hydrocyanation |
| 03/16/2005 | CN1594334A Process for the preparation of n-(phosphonomethyl)glycine by oxidizing n-substituted n-(phosphonomethyl)glycine |
| 03/16/2005 | CN1594333A Process for synthesizing liquid crystal compound by catalytic cross-coupling of diphenyl-phosphino- palladium acetate |
| 03/16/2005 | CN1594332A Glycyrrhetic acid and phospholipid composites of glycyrrhetate and process for preparing same |
| 03/16/2005 | CN1594293A Process for synthesizing lacidipine of antihypertensive drugs |
| 03/16/2005 | CN1193035C Process for preparation of sphingolipids and sphingolipid derivatives |
| 03/16/2005 | CN1193033C Tris (oxalato) phosphates, preparation method and use thereof |
| 03/16/2005 | CN1193032C Method of preparing disodium methyl nitrozole phosphate |
| 03/16/2005 | CN1193031C Salt of melamine condensation product and phosphorus-containing salt |
| 03/16/2005 | CN1192992C Method for producing alcohol surfactants and alcohol ether surfactants, products obtained and their use |
| 03/15/2005 | US6867330 Halogenated phosphines |
| 03/15/2005 | US6867326 Preparing N-phosphonomethylglycine or a salt thereof by oxidizingphosphonomethyliminodiacetic acid or a salt |
| 03/15/2005 | US6867310 Synthesize efficiently and under mild conditions alpha -aryl and alpha -vinyl products from a wide range of starting materials, including ketones, esters, hydrazones, and imines, enantiomorphs |
| 03/15/2005 | US6867298 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency |
| 03/15/2005 | US6867215 Cardioprotective phosphonates and malonates |
| 03/15/2005 | US6867200 Anticancer agents; anticoagulants |